Pharmaceutical compositions comprising a cyclosporin in a novel galenic
formulations for oral administration. The compositions typically comprise
a cyclosporin, 1,2-propylene glycol, a mixed mono-, di- and tri-glyceride
and a hydrophilic surfactant. Further a refined glycerol-transesterified
corn oil is provided representing a mixed mono-, di- and tri-glyceride
suitable for the novel formulation. Dosage forms include in particular
oral dosage forms.
